New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

3

AstraZeneca Announces Potential Breakthrough in Advanced Biliary Tract Cancer

AstraZeneca shared positive results from the company’s TOPAZ-1 Phase III trial on Imfinzi (durvalumab) in increasing the chances for survival in advanced biliary tract cancer patients when combined with standard-of-care chemotherapy regimens.

5

Regeneron, Sanofi on a Roll as Dupixent Scores Second Consecutive Phase III Win

Dupixent (dupilumab) scored the blockbuster medicine’s second study win in a week after Regeneron Pharmaceuticals and Sanofi revealed positive results from the second Phase III trial for the treatment of eosinophilic esophagitis (EoE).